{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:37:27Z","timestamp":1726015047771},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardio Med"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1007\/s11936-000-0006-1","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T06:14:38Z","timestamp":1180851278000},"page":"135-139","source":"Crossref","is-referenced-by-count":9,"title":["Primary pulmonary hypertension"],"prefix":"10.1007","volume":"2","author":[{"given":"Stuart","family":"Rich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"6_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","volume":"336","author":"LJ Rubin","year":"1997","unstructured":"Rubin LJ: Primary pulmonary hypertension. N Engl J Med 1997, 336:111\u2013117. This article provides a comprehensive review of primary pulmonary hypertension from a clinical perspective.","journal-title":"N Engl J Med"},{"key":"6_CR2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","volume":"335","author":"L Abenhaim","year":"1996","unstructured":"Abenhaim L, Moride Y, Brenot F, et al.: Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996, 335:609\u2013616.","journal-title":"N Engl J Med"},{"key":"6_CR3","unstructured":"Executive summary from the World Symposium on Primary Pulmonary Hypertension 1998 Web page. http:\/\/www.who.int\/ncd\/cvd\/pph.html."},{"key":"6_CR4","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1161\/01.CIR.95.12.2603","volume":"95","author":"JH Morse","year":"1997","unstructured":"Morse JH, Jones AC, Barst RJ, et al.: Mapping of familial primary pulmonary hypertension locus (PPH1) to chromosome 2q31-32. Circulation 1997, 95:2603\u20132606.","journal-title":"Circulation"},{"key":"6_CR5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0735-1097(98)00361-1","volume":"32","author":"MJ Ricciardi","year":"1998","unstructured":"Ricciardi MJ, Knight BP, Martinez FJ, et al.: Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine. J Am Coll Cardiol 1998, 32:1068\u20131073.","journal-title":"J Am Coll Cardiol"},{"key":"6_CR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199801293380501","volume":"338","author":"VV McLaughlin","year":"1998","unstructured":"McLaughlin VV, Genthner DE, Panella MM, et al.: Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998, 338:273\u2013277. This study describes the short- and long-term effects of prostacyclin as a therapy for pulmonary hypertension and supplies unique data supporting the possibility that prostacyclin may cause reversal of vascular remodeling.","journal-title":"N Engl J Med"},{"key":"6_CR7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.CIR.76.1.135","volume":"76","author":"S Rich","year":"1987","unstructured":"Rich S, Brundage BH: High-dose calcium channelblocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Circulation 1987, 76:135\u2013141.","journal-title":"Circulation"},{"key":"6_CR8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","volume":"327","author":"S Rich","year":"1992","unstructured":"Rich S, Kaufmann E, Levy PS: The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992, 327:76\u201381. This paper describes the effectiveness of calcium channel blockers and warfarin anticoagulants in prolonging survival in patients with primary pulmonary hypertension.","journal-title":"N Engl J Med"},{"key":"6_CR9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0735-1097(84)80048-0","volume":"4","author":"M Packer","year":"1984","unstructured":"Packer M, Medina N, Yushak M: Adverse hemodynamic and clinical effects of calcium channel blockage in pulmonary hypertension secondary to obliterative pulmonary vascular disease. J Am Coll Cardiol 1984, 4:890\u2013901.","journal-title":"J Am Coll Cardiol"},{"key":"6_CR10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","volume":"334","author":"RJ Barst","year":"1996","unstructured":"Barst RJ, Rubin LJ, Long WA, et al.: A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996, 334:296\u2013301.","journal-title":"N Engl J Med"},{"key":"6_CR11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0735-1097(97)00187-3","volume":"30","author":"SM Shapiro","year":"1997","unstructured":"Shapiro SM, Oudiz RJ, Cao T, et al.: Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coll Cardiol 1997, 30:343\u2013349.","journal-title":"J Am Coll Cardiol"},{"key":"6_CR12","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-130-9-199905040-00014","volume":"130","author":"VV McLaughlin","year":"1999","unstructured":"McLaughlin VV, Genthner DE, Panella MM, et al.: Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series. Ann Intern Med 1999, 130:740\u2013743.","journal-title":"Ann Intern Med"},{"key":"6_CR13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM198203113061001","volume":"306","author":"BA Reitz","year":"1982","unstructured":"Reitz BA, Wallwork JL, Hunt SA, et al.: Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982, 306:557\u2013564.","journal-title":"N Engl J Med"},{"key":"6_CR14","first-page":"259","volume":"25","author":"LR Kaiser","year":"1992","unstructured":"Kaiser LR, Cooper JD: The current status of lung transplantation. Adv Surg 1992, 25:259\u2013307.","journal-title":"Adv Surg"},{"key":"6_CR15","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/oxfordjournals.eurheartj.a015478","volume":"18","author":"G Mikhail","year":"1997","unstructured":"Mikhail G, Gibbs J, Richardson M, et al.: An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension. Eur Heart J 1997, 18:1499\u20131504.","journal-title":"Eur Heart J"},{"key":"6_CR16","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0002-9149(96)90408-7","volume":"78","author":"T Saji","year":"1996","unstructured":"Saji T, Ozawa Y, Ishikita T, et al.: Short-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertension. Am J Cardiol 1996, 78:244\u2013247.","journal-title":"Am J Cardiol"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-000-0006-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-000-0006-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-000-0006-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:52:25Z","timestamp":1559436745000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-000-0006-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s11936-000-0006-1","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}